Sunbelt Securities’s Acadia Pharmaceuticals ACAD Stock Holding History

Sunbelt Securities’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05K	Sell	47 -6	-11%	-$143	﹤0.01%	2083
2025 Q4	$1.42K	Hold	53	–	–	﹤0.01%	1970
2025 Q3	$1.13K	Buy	+53	New	+$1.25K	﹤0.01%	2017
2022 Q2	–	Sell	-8,231	Closed	-$201K	–	439
2022 Q1	$201K	Hold	8,231	–	–	0.04%	438
2021 Q4	$207K	Buy	+8,231	New	+$166K	0.03%	437
2021 Q2	–	Sell	-8,231	Closed	-$212K	–	439
2021 Q1	$212K	Hold	8,231	–	–	0.04%	391
2020 Q4	$440K	Hold	8,231	–	–	0.09%	247
2020 Q3	$340K	Buy	+8,231	New	+$355K	0.09%	242

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Sunbelt Securities's ACAD Position: Q1 2026 in Review

Sunbelt Securities reduced its Acadia Pharmaceuticals (ACAD) stake by 11% in Q1 2026, selling an estimated $143 and leaving 47 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Sunbelt Securities first reported a position in ACAD in Q3 2020 and has held it in 8 quarters since. The position peaked at $440K in Q4 2020. 343 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

Sunbelt Securities held 47 shares of Acadia Pharmaceuticals worth $1.05K as of Q1 2026.
Sunbelt Securities sold 6 Acadia Pharmaceuticals shares in Q1 2026, an estimated $143.
Acadia Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2083 holding.
Sunbelt Securities first reported a position in Acadia Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
Sunbelt Securities's Acadia Pharmaceuticals position peaked at $440K in Q4 2020.
343 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.